Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Self‐Reporting Fluorescent Salicylaldehyde–Chlorambucil Conjugate as a Type‐II ICD Inducer for Cancer Vaccines
Minjie Zhang, Xin Jin, Meng Gao, et al.
Advanced Materials (2022) Vol. 34, Iss. 36
Closed Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Augmenting Immunotherapy via Bioinspired MOF‐Based ROS Homeostasis Disruptor with Nanozyme‐Cascade Reaction
Ruifang Wang, Maosong Qiu, Lei Zhang, et al.
Advanced Materials (2023) Vol. 35, Iss. 49
Closed Access | Times Cited: 65
Immuno-photodynamic Therapy (IPDT): Organic Photosensitizers and Their Application in Cancer Ablation
Lu Yang, Wen Sun, Jianjun Du, et al.
JACS Au (2023) Vol. 3, Iss. 3, pp. 682-699
Open Access | Times Cited: 62
Augmenting Cancer Therapy with a Supramolecular Immunogenic Cell Death Inducer: A Lysosome-Targeted NIR-Light-Activated Ruthenium(II) Metallacycle
Le Tu, Chonglu Li, Qihang Ding, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 13, pp. 8991-9003
Closed Access | Times Cited: 47
Amplifying “eat me signal” by immunogenic cell death for potentiating cancer immunotherapy
Yong Xi, Lijie Chen, Jian Tang, et al.
Immunological Reviews (2023) Vol. 321, Iss. 1, pp. 94-114
Closed Access | Times Cited: 44
Rational design of ICD-inducing nanoparticles for cancer immunotherapy
Zhanzhan Zhang, Zheng Pan, Qiushi Li, et al.
Science Advances (2024) Vol. 10, Iss. 6
Open Access | Times Cited: 21
Endoplasmic Reticulum‐Targeting Iridium(III) Nanosonosensitizer Amplifies Immunogenic Cell Death for Boosted Tumor Sono‐Immunotherapy
Xiaoyu Xu, Meixu Chen, Shan Jiang, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 26
Closed Access | Times Cited: 19
Recent Advances in Strategies to Enhance Photodynamic and Photothermal Therapy Performance of Single‐Component Organic Phototherapeutic Agents
Laiping Fang, Zengzhen Chen, Jianan Dai, et al.
Advanced Science (2025)
Open Access | Times Cited: 3
Self-Immolative Photosensitizers for Self-Reported Cancer Phototheranostics
Chunfei Wang, Yongjie Sun, Shaojuan Huang, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 24, pp. 13099-13113
Closed Access | Times Cited: 36
A Near-Infrared-II Fluorescent Nanocatalyst for Enhanced CAR T Cell Therapy against Solid Tumor by Immune Reprogramming
Haimei Li, Xiuxiu Yang, Zichen Wang, et al.
ACS Nano (2023) Vol. 17, Iss. 12, pp. 11749-11763
Closed Access | Times Cited: 26
A NIR‐Light‐Activated and Lysosomal‐Targeted Pt(II) Metallacycle for Highly Potent Evoking of Immunogenic Cell Death that Potentiates Cancer Immunotherapy of Deep‐Seated Tumors
Chonglu Li, Le Tu, Yuling Xu, et al.
Angewandte Chemie International Edition (2024) Vol. 63, Iss. 37
Closed Access | Times Cited: 14
Boosting Sono-immunotherapy of Prostate Carcinoma through Amplifying Domino-Effect of Mitochondrial Oxidative Stress Using Biodegradable Cascade-Targeting Nanocomposites
Yandong Wang, Haodong Li, Guiming Niu, et al.
ACS Nano (2024)
Closed Access | Times Cited: 11
Emerging plasmonic nanoparticles and their assemblies for cancer radiotherapy
Ying Wu, Kang Zhu, Xuan Zhang, et al.
Advanced Drug Delivery Reviews (2023) Vol. 194, pp. 114710-114710
Closed Access | Times Cited: 20
A Cascade‐Targeted Enzyme‐Instructed Peptide Self‐Assembly Strategy for Cancer Immunotherapy through Boosting Immunogenic Cell Death
Li‐Min Xie, Yinghao Ding, Xiangyang Zhang, et al.
Small Methods (2023) Vol. 7, Iss. 5
Closed Access | Times Cited: 19
Smart drug delivery systems to overcome drug resistance in cancer immunotherapy
Wenzhe Yi, Dan Yan, Dangge Wang, et al.
Cancer Biology and Medicine (2023) Vol. 20, Iss. 4, pp. 248-267
Open Access | Times Cited: 17
Enhanced optical imaging and fluorescent labeling for visualizing drug molecules within living organisms
Ting Sun, Huanxin Zhao, Luyao Hu, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 6, pp. 2428-2446
Open Access | Times Cited: 7
In situ tumor vaccine with optimized nanoadjuvants and lymph node targeting capacity to treat ovarian cancer and metastases
Yuan Li, Fan Tong, Yufan Wang, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 9, pp. 4102-4117
Open Access | Times Cited: 7
Triboelectric immunotherapy using electrostatic-breakdown induced direct-current
Haimei Li, Chao-Yu Chen, Zichen Wang, et al.
Materials Today (2023) Vol. 64, pp. 40-51
Closed Access | Times Cited: 16
Unfolded Protein-Based Sandwich AIE Probe Imparts High Fluorescent Contrast for Pan-Cancer Surgical Navigation
Quan Wang, Biao Chen, Chong Duan, et al.
Analytical Chemistry (2024) Vol. 96, Iss. 8, pp. 3609-3617
Closed Access | Times Cited: 5
Local Drug Delivery Techniques for Triggering Immunogenic Cell Death
En Ren, Yanfang Wang, Tingxizi Liang, et al.
Small Methods (2023) Vol. 7, Iss. 9
Closed Access | Times Cited: 12
Developing a Hetero-Trinuclear Erbium(III)–Copper(II) Complex Based on Apoferritin: Targeted Photoacoustic Imaging and Multimodality Therapy of Tumor
Minghui Zhu, Xueyu Man, Yang Tongfu, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 22, pp. 15424-15436
Closed Access | Times Cited: 11
A fully biodegradable spherical nucleic acid nanoplatform for self-codelivery of doxorubicin and miR122 for innate and adaptive immunity activation
Ming-Chao Jiang, Zhou-Long Fang, Jinyan Zhang, et al.
Acta Biomaterialia (2024) Vol. 180, pp. 407-422
Closed Access | Times Cited: 4
Zn/Cu Bi‐Single‐Atom Nanoplatform: Hexagonal Anti‐Tumor Warrior by ROS Amplification for DOX Resistance Reversal and Immune Activation
Tianyi Wang, Fenglan Zhang, Carlos F. Guimarães, et al.
Advanced Functional Materials (2024)
Closed Access | Times Cited: 4
A Nanoimmunoactivator Induces Endoplasmic Reticulum Stress and Alleviates the Immunosuppression for Synergistic Cancer Immunotherapy
Hui Qi, Zhanzhan Zhang, Yu Zhao, et al.
Advanced Functional Materials (2025)
Closed Access
An efficient ICD inducer based on Ir(III) cyclometalated complex for anticancer and anti-migration effects towards cisplatin-resistant cancer cells
Jingyue Zhao, Xiangyu Dai, Mengdi Lv, et al.
Inorganica Chimica Acta (2025), pp. 122601-122601
Closed Access
A stimuli-responsive immunostimulant to activate chemo-immunotherapeutic effects by inducing DNA damage and STING activation
Shuiying Zhang, Hangyu Zhou, Yixin Liu, et al.
Journal of Colloid and Interface Science (2025) Vol. 688, pp. 664-676
Closed Access
Page 1 - Next Page

Scroll to top